Publikationen, an denen er mitarbeitet DAVID LORA PABLOS (4)

2022

  1. Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial

    The Lancet Haematology, Vol. 9, Núm. 6, pp. e425-e433

2017

  1. DEK oncogene is overexpressed during melanoma progression

    Pigment Cell and Melanoma Research, Vol. 30, Núm. 2, pp. 194-202

  2. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine

    Nature, Vol. 546, Núm. 7660, pp. 676-680

2016

  1. The new Cutaneous Lymphoma International Prognostic index (CLIPi) for early mycosis fungoides failed to identify prognostic groups in a cohort of Spanish patients

    British Journal of Dermatology